Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
Medve L, Csitári IK, Molnár Z, László A
Department of Anesthesiology, Szent Lázár County Hospital, Salgótarján, Hungary. medve561@axelero.hu
Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.
Published 9 September 2005 in Am J Obstet Gynecol, 193(3): 864-5.
Full-text of this article is available online (may require subscription).
© 2004-2008 Cranberry Research Today. All Rights Reserved.
| 
